Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • P744: A REAL-WORLD STUDY OF MU...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
P744: A REAL-WORLD STUDY OF MULTIPLE-CYCLE HYPOMETHYLATING AGENTS MONOTHERAPY IN MYELODYSPLASTIC SYNDROMES

P744: A REAL-WORLD STUDY OF MULTIPLE-CYCLE HYPOMETHYLATING AGENTS MONOTHERAPY IN MYELODYSPLASTIC SYNDROMES

Bibliographic Details
Main Authors: Xiaozhen Liu, Huifang Jiang, Guifang Ouyang, Shujuan Zhou, Jiang Huang, Jin Zhang, Caifang Zhao, Yanping Shao, Gongqiang Wu, Xibin Xiao, Chen Mei, Gaixiang Xu, Liya MA, Xinping Zhou, Yanling Ren, Hongyan Tong
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000969880.82508.fa
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://journals.lww.com/10.1097/01.HS9.0000969880.82508.fa

Similar Items

  • A real-world experience of venetoclax combined with hypomethylating agents vs. monotherapy hypomethylating agents in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia patients
    by: Ludan Zhang, et al.
    Published: (2024-05-01)
  • Serial monitoring of circulating tumour DNA on clinical outcome in myelodysplastic syndromes and acute myeloid leukaemia
    by: Xinping Zhou, et al.
    Published: (2023-07-01)
  • Meta-analysis on hypomethylating agents in myelodysplastic syndromes
    by: Christine Herbst, et al.
    Published: (2010-02-01)
  • Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes
    by: Xuefen Yan, et al.
    Published: (2021-03-01)
  • Therapeutic Options in Myelodysplastic Syndromes Following Hypomethylating Agent Failure
    by: Abigail Belasen, et al.
    Published: (2020-07-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs